CN Stock MarketDetailed Quotes

KPC Pharmaceuticals, Inc. (600422)

Watchlist
  • 8.93
  • -0.23-2.51%
Market Closed May 14 15:00 CST
6.76BMarket Cap57.61P/E (TTM)

KPC Pharmaceuticals, Inc. (600422) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
药品、器械批发与零售3.27B49.74%
Field of cardio-cerebral vascular therapy1.73B26.32%
Other453.27M6.89%
digestive system314.48M4.78%
Gynecology Department304.23M4.63%
Other business303.38M4.61%
Orthopedic series108.02M1.64%
Antimalarial species90.45M1.38%
View all

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
药品、器械批发与零售3.27B49.74%
Oral agent2.31B35.18%
Injection606.76M9.23%
Other business303.38M4.61%
Other81.39M1.24%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
Domestic6.14B93.36%
Other business303.38M4.61%
Abroad133.03M2.02%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More